Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valery Radchenko

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
Nuclear Medicine and Biology|January 18, 2021
Potent candidates for Targeted Auger Therapy: Production and radiochemical considerationsDmitry Filosofov, Elena Kurakina, Valery Radchenko
Nuclear Medicine and Biology|August 4, 2014
Desferrioxamine as an appropriate chelator for 90Nb: comparison of its complexation properties for M-Df-Octreotide (M = Nb, Fe, Ga, Zr)Valery Radchenko, Stefan Busse, Frank Roesch
Chempluschem|July 24, 2024
Chemistry of Antimony in Radiopharmaceutical Development: Unlocking the Theranostic Potential of Sb IsotopesAivija Grundmane, Valery Radchenko, Caterina F Ramogida
EJNMMI Radiopharmacy and Chemistry|June 27, 2026
Recycling-compatible electroplating of enriched tin-119 targets for the production of antimony-119 for targeted Auger electron therapyAivija Grundmane, Caterina F Ramogida, Valery Radchenko
Nuclear Medicine and Biology|February 19, 2021
Potential for production of medical radionuclides with on-line isotope separation at the ISAC facility at TRIUMF and particular discussion of the examples of <sup>165</sup>Er and <sup>155</sup>TbDesiree Erika Fiaccabrino, Peter Kunz, Valery Radchenko
Inorganic Chemistry|February 7, 2024
High Separation Factor, High Molar Activity, and Inexpensive Purification Method for the Production of Pure <sup>165</sup>ErBehrad Saeedi Saghez, Hua Yang, Valery Radchenko
Nuclear Medicine and Biology|April 25, 2025
Novel dibutyl ether resin for the purification of the Auger emitter antimony-119 from tin targetsAivija Grundmane, Caterina F Ramogida, Valery Radchenko
Nuclear Medicine and Biology|May 27, 2025
Potent candidates for Targeted Alpha Therapy (TAT)Dmitry Filosofov, Ayagoz Baimukhanova, Jurabek Khushvaktov, et al.
Inorganic Chemistry|February 26, 2021
Chemical Promiscuity of Non-Macrocyclic Multidentate Chelating Ligands for Radiometal Ions: H<sub>4</sub>neunpa-NH<sub>2</sub> <i>vs</i> H<sub>4</sub>noneunpaLuke Wharton, Elena Kurakina, Valery Radchenko, et al.
Current Radiopharmaceuticals|April 17, 2018
Development of <sup>225</sup>Ac Radiopharmaceuticals: TRIUMF Perspectives and ExperiencesAndrew Kyle Henderson Robertson, Caterina Fortunata Ramogida, Paul Schaffer, et al.
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
Nuclear Medicine and Biology|January 18, 2021
Potent candidates for Targeted Auger Therapy: Production and radiochemical considerationsDmitry Filosofov, Elena Kurakina, Valery Radchenko
Nuclear Medicine and Biology|August 4, 2014
Desferrioxamine as an appropriate chelator for 90Nb: comparison of its complexation properties for M-Df-Octreotide (M = Nb, Fe, Ga, Zr)Valery Radchenko, Stefan Busse, Frank Roesch
Chempluschem|July 24, 2024
Chemistry of Antimony in Radiopharmaceutical Development: Unlocking the Theranostic Potential of Sb IsotopesAivija Grundmane, Valery Radchenko, Caterina F Ramogida
EJNMMI Radiopharmacy and Chemistry|June 27, 2026
Recycling-compatible electroplating of enriched tin-119 targets for the production of antimony-119 for targeted Auger electron therapyAivija Grundmane, Caterina F Ramogida, Valery Radchenko
Nuclear Medicine and Biology|February 19, 2021
Potential for production of medical radionuclides with on-line isotope separation at the ISAC facility at TRIUMF and particular discussion of the examples of <sup>165</sup>Er and <sup>155</sup>TbDesiree Erika Fiaccabrino, Peter Kunz, Valery Radchenko
Inorganic Chemistry|February 7, 2024
High Separation Factor, High Molar Activity, and Inexpensive Purification Method for the Production of Pure <sup>165</sup>ErBehrad Saeedi Saghez, Hua Yang, Valery Radchenko
Nuclear Medicine and Biology|April 25, 2025
Novel dibutyl ether resin for the purification of the Auger emitter antimony-119 from tin targetsAivija Grundmane, Caterina F Ramogida, Valery Radchenko
Nuclear Medicine and Biology|May 27, 2025
Potent candidates for Targeted Alpha Therapy (TAT)Dmitry Filosofov, Ayagoz Baimukhanova, Jurabek Khushvaktov, et al.
Inorganic Chemistry|February 26, 2021
Chemical Promiscuity of Non-Macrocyclic Multidentate Chelating Ligands for Radiometal Ions: H<sub>4</sub>neunpa-NH<sub>2</sub> <i>vs</i> H<sub>4</sub>noneunpaLuke Wharton, Elena Kurakina, Valery Radchenko, et al.
Current Radiopharmaceuticals|April 17, 2018
Development of <sup>225</sup>Ac Radiopharmaceuticals: TRIUMF Perspectives and ExperiencesAndrew Kyle Henderson Robertson, Caterina Fortunata Ramogida, Paul Schaffer, et al.
Pageof 8